e.l.f. Beauty stock plummets 20% as revenue and guidance fall short of expectations
Investing.com - William Blair downgraded AptarGroup (NYSE:ATR) from Outperform to Market Perform, citing concerns about growth prospects over the next several quarters. The downgrade comes as the stock has fallen 9.92% over the past week and 23.18% over the last six months.
The downgrade follows revelations that Narcan-related headwinds will continue to impact the company’s performance longer than previously anticipated, according to William Blair’s analysis. InvestingPro data shows that 5 analysts have recently revised their earnings expectations downward for the upcoming period, aligning with this cautious outlook.
The research firm expects AptarGroup to face muted growth over at least the next three quarters, with profitability under pressure due to mix shift dynamics.
William Blair noted that while the long-term strategy focused on shifting toward pharmaceutical products remains intact, the stock will likely struggle to outperform without ongoing evidence of progress in this area.
AptarGroup shares currently trade at 19.5 times William Blair’s 2026 adjusted EPS estimate, compared to the company’s average multiple of 26.4 times since acquiring Stelmi in 2012.
In other recent news, AptarGroup Inc . reported its third-quarter 2025 earnings, exceeding analysts’ expectations with earnings per share (EPS) of $1.62 compared to the forecast of $1.57. Despite this positive earnings surprise, broader market concerns and specific guidance issues have emerged. The company’s stock experienced a decline, although stock price movements are not the focus here. These developments highlight the complexities AptarGroup faces amid the current market environment. The earnings report underscores the company’s ability to perform above analyst projections, even as external factors weigh on its stock performance. Investors may look to further updates from AptarGroup to better understand the company’s future guidance and market positioning.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.